Assignee
BIOMIRA INC
CA·16 granted patents·4 pending applications·308 citations·filing 1988–2004
Top patents by PatentIndex Score
20 records- 0190US6600012B1Lipid-modified muc-1 derivativesBIOMIRA INC·Filed 2000·Granted Jul 29, 2003·43 cites·16 claims
- 0286US5110911AHuman tumor-associated thomsen-friedenreich antigenBIOMIRA INC·Filed 1989·Granted May 5, 1992·84 cites·6 claims
- 0382USRE38046EEnhancement of the cellular immune responseBIOMIRA INC·Filed 2000·Granted Mar 25, 2003·10 cites·63 claims
- 0474US7491707B1Synthetic lipid-a-analogs and uses thereofBIOMIRA INC·Filed 2000·Granted Feb 17, 2009·16 cites·69 claims
- 0567US6013779AProcess for preparation of glycosides of tumor-associated carbohydrate antigensBIOMIRA INC·Filed 1997·Granted Jan 11, 2000·34 cites·23 claims
- 0659US5242799ALectin-antibody immunoassays for TF epitope-bearing antigensBIOMIRA INC·Filed 1992·Granted Sep 7, 1993·27 cites·24 claims
- 0758US6582697B2Enhancement of the cellular immune responseBIOMIRA INC·Filed 2001·Granted Jun 24, 2003·0 cites·14 claims
- 0858US5798090AEnhancement of the cellular immune responseBIOMIRA INC·Filed 1995·Granted Aug 25, 1998·14 cites·10 claims
- 0958US5075218AScreening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereofBIOMIRA INC·Filed 1988·Granted Dec 24, 1991·28 cites·17 claims
- 1057US5055562AFluorocarbon chain-containing antigenic conjugatesBIOMIRA INC·Filed 1988·Granted Oct 8, 1991·22 cites·24 claims
- 1151US4971795AEnhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotypeBIOMIRA INC·Filed 1988·Granted Nov 20, 1990·11 cites·9 claims
- 1247US2006069238A1Synthetic glyco-lipo-peptides as vaccinesBIOMIRA INC·Filed 2003·Application pending·0 cites
- 1346US4935503AAzidochlorination and diazidization of glycalsBIOMIRA INC·Filed 1988·Granted Jun 19, 1990·7 cites·31 claims
- 1443US2006116331A1Glycosylceramide analoguesBIOMIRA INC·Filed 2003·Application pending·0 cites
- 1541US6114129AMethods of detecting T-cell activation and treating disorders associated with T-cell dysfunctionBIOMIRA INC·Filed 1999·Granted Sep 5, 2000·7 cites·5 claims
- 1639US2002142983A1MUC-1 antagonists and methods of treating immune disordersBIOMIRA INC·Filed 2001·Application pending·0 cites
- 1739US2008081045A1Combination Therapy for CancerBIOMIRA INC·Filed 2004·Application pending·0 cites
- 1837US5527891AStereodirected process for synthesis of α-N-acetylgalactosaminidesBIOMIRA INC·Filed 1994·Granted Jun 18, 1996·3 cites·10 claims
- 1930US6326009B1Enhancement of the cellular immune responseBIOMIRA INC·Filed 1998·Granted Dec 4, 2001·0 cites·61 claims
- 2028US5837830AStereodirected process for synthesis of α-N-acetylgalactosaminidesBIOMIRA INC·Filed 1996·Granted Nov 17, 1998·2 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when BIOMIRA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →